DISEASE PROGRESSION side effect
What is DISEASE PROGRESSION ?Drugs associated with DISEASE PROGRESSION
ABRAXANE ACCUTANE ACETAZOLAMIDE ACTIVASE ACTONEL ACTOPLUS ACTOS ACYCLOVIR ADRIBLASTINE ADVAIR AGGRASTAT ALDACTONE ALDURAZYME ALIMTA ALISKIREN ALKERAN AMANTADINE AMBISOME AMMONUL AMPHOTERICIN ANAGRELIDE ARAVA AREDIA ARICEPT ARIMIDEX ARIXTRA AROMASIN ASMANEX AUGMENTIN AVASTIN AVONEX BACLOFEN BENADRYL BETAMETHASONE BETASERON BEVACIZUMAB BEXXAR BONDRONAT BORTEZOMIB BUMETANIDE CABASER CALCIUM CAMPTOSAR CAP CAPECITABINE CAPHOSOL CARBOPLATIN CEFTAZIDIME CELEBREX CELLCEPT CEREZYME CERTICAN CETUXIMAB CICLOSPORIN CILOSTAZOL CIPROFLOXACIN CISPLATIN CLARAVIS CLIMARA CLOFARABINE CLOZAPINE COLACE COMBIVENT COMTAN COPAXONE COREG CORTANCYL COVIRO CUBICIN CYCLOPHOSPHAMIDE CYTARABINE CYTOVENE CYTOXAN DACARBAZINE DACOGEN DASATINIB DECADRON DECITABINE DEPOCYT DEXAMETHASONE DEXTROSE DIDANOSINE DILAUDID DIOVAN DOCETAXEL DOXIL DOXORUBICIN DURAGESIC DUROTEP DYSPORT EFFEXOR ELAPRASE ELIDEL ELISOR ENBREL EPIRUBICIN ERBITUX ERLOTINIB ETOPOSIDE EXELON EXJADE FABRAZYME FAZACLO FENOFIBRATE FENTORA FLOLAN FLORINEF FLUCONAZOLE FLUDARABINE FLUOROURACIL FOLINIC FOLLITROPIN FUZEON GABAPENTIN GABITRIL GEFITINIB GEMCITABINE GEMTUZUMAB GEMZAR GLEEVEC GLIADEL HEPARIN HERCEPTIN HIGH IBUPROFEN IFOMIDE IFOSFAMIDE IMATINIB INFLIXIMAB INTERFERON IRESSA IRINOTECAN ISOTRETINOIN ITRACONAZOLE KEPPRA KINERET LAPATINIB LAPATINIBLET LEUCOVORIN LEVOFLOXACIN LEXAPRO LIORESAL LOTREL LUCENTIS LYRICA MEMANTINE METHOTREXATE METRONIDAZOLE MIGLUSTAT MIRAPEX MORPHINE MST MYCOPHENOLATE MYCOPHENOLIC MYFORTIC MYLOTARG MYOZYME NAGLAZYME NATALIZUMAB NATEGLINIDE NAVELBINE NELFINAVIR NEORAL NEXAVAR NILOTINIB NORDITROPIN NOVANTRONE NOVOSEVEN NOXAFIL OMNISCAN OXALIPLATIN OXANDRIN OXYCONTIN PACLITAXEL PACLITAXELECTION PACLITAZELECTION PALLADONE PANITUMUMAB PEMETREXED PRAVASTATIN PREDNISONE PROCRIT PROGRAF PROPRANOLOL RANIBIZUMAB RAPAMYCIN RAPTIVA REBIF REMICADE REVLIMID RIFATER RITONAVIR RITUXAN ROCEPHIN SAIZEN SANDIMMUNE SANDOSTATIN SEBIVO SERETIDE SEROQUEL SEVREDOL SILDENAFIL SIMETHICONE SINEMET SORAFENIB STALEVO SUDAFED SULPERAZON SUNITINIB SUTENT TAMOXIFEN TARCEVA TARGRETIN TAXOTERE TEMODAL TEMODAR TEMOZOLOMIDE TEMSIROLIMUS THALIDOMIDE THALOMID TICLOPIDINE TOPOTECAN TORISEL TRACLEER TRASTUZUMAB TRIOMUNE TYKERB TYSABRI TYVERB URSODIOL VAGIFEM VALPROIC VECTIBIX VELCADE VENTAVIS VESICARE VFEND VISUDYNE VITAMIN WARFARIN WELLBUTRIN XELODA XYREM ZANTAC ZELNORM ZEVALIN ZIDOVUDINE ZOCOR ZOLADEX ZOLEDRONATE ZOLEDRONIC ZOLINZA ZOMETA ZONEGRAN ZYPREXA ZYVOXDISEASE PROGRESSION : Sutent Side Effects Report #5649563-9
Physician from AUSTRALIA reported SUTENT problem on Feb 21, 2008. Male patient, weighting 200.6 lb, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspepsia, nausea, oesophagitis, vomiting, . SUTENT dosage: unknown. Patient recovered.
DISEASE PROGRESSION : Erlotinib Side Effects Report #5652116-X
ERLOTINIB problem was reported by a Health Professional from JAPAN on Feb 19, 2008. Male patient, 65 years of age, was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperkalaemia, . ERLOTINIB dosage: 160 MG, QD, ORAL. During the same period patient was treated with RABEPRAZOLE, ALLOPURINOL, TEGRETOL, METHYCOBAL, OXYCONTIN. Patient died on 01/30/2008.
DISEASE PROGRESSION : Revlimid Side Effects Report #5652142-0
Physician from SWITZERLAND reported REVLIMID problem on Feb 25, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: unknown. Patient died.
DISEASE PROGRESSION : Bondronat Side Effects Report #5655348-X
BONDRONAT problem was reported by a Physician from GERMANY on Feb 25, 2008. Female patient, 57 years of age, was treated with BONDRONAT. After drug was administered, patient experienced the following problems/side effects: disease progression, ill-defined disorder, metastases to bone, . BONDRONAT dosage: unknown. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died.
DISEASE PROGRESSION : Avastin Side Effects Report #5655964-5
Consumer or non-health professional from UNITED KINGDOM reported AVASTIN problem on Feb 22, 2008. Male patient was diagnosed with rectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, . AVASTIN dosage: 671 MG, UNK. Patient died on 04/01/2007.
DISEASE PROGRESSION : Temodal Side Effects Report #5656219-5
TEMODAL problem was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Female patient, 83 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, glioblastoma, . TEMODAL dosage: 150 MG/M2; ; PO, 200 MG/M2; ; PO. Patient died on 10/10/2007.
DISEASE PROGRESSION : Ibuprofen Side Effects Report #5656264-X
Health Professional from GERMANY reported IBUPROFEN problem on Feb 14, 2008. Male patient was diagnosed with pain, infection prophylaxis, hypertension, thrombosis prophylaxis, depression and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: disease progression, overdose, polyarthritis, stevens-johnson syndrome, . IBUPROFEN dosage: (1200 MG ORAL). During the same period patient was treated with AUGMENTIN, NOVALGIN, BAYOTENSIN, LOPIRIN, OXYGESIC, REMERGIL, ANTRA. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Gemcitabine Side Effects Report #5657233-6
GEMCITABINE problem was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, weighting 114.6 lb, was diagnosed with squamous cell carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, respiratory failure, . GEMCITABINE dosage: 3000 MG/M2 IV Q 2 WEEKS. During the same period patient was treated with DOCETAXEL. Patient died on 02/09/2008.
DISEASE PROGRESSION : Sutent Side Effects Report #5657431-1
Physician from AUSTRALIA reported SUTENT problem on Feb 27, 2008. Male patient, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. Patient died.
DISEASE PROGRESSION : Mycophenolate Side Effects Report #5657657-7
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Feb 29, 2008. Female patient, 67 years of age, weighting 130.1 lb, was diagnosed with heart transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperglycaemia, pericardial drainage, pericardial effusion, productive cough, troponin increased, vision blurred, . MYCOPHENOLATE MOFETIL dosage: 0.75 MG, BID. During the same period patient was treated with BACTRIM, VALCYTE, PREDNISONE, INSULIN, NEORAL. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Cyclophosphamide Side Effects Report #5659498-3
Consumer or non-health professional from DENMARK reported CYCLOPHOSPHAMIDE problem on Mar 07, 2008. Female patient, 60 years of age, weighting 165.3 lb, was diagnosed with metastases to bone and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, osteonecrosis, tooth extraction, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, ZOMETA. Patient died on 08/11/2007.
DISEASE PROGRESSION : Temodal Side Effects Report #5660490-3
TEMODAL problem was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Male patient, 76 years of age, weighting 121.3 lb, was diagnosed with malignant glioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant glioma, . TEMODAL dosage: 150 MG/M2; ; PO, 320 MG; QD; PO. During the same period patient was treated with HYPNOVEL, SCOPOLAMINE, MORPHINE. Patient died on 09/12/2007.
DISEASE PROGRESSION : Tamoxifen Side Effects Report #5660886-X
Consumer or non-health professional from UNITED STATES reported TAMOXIFEN problem on Mar 05, 2008. Female patient, 66 years of age, weighting 182.1 lb, was diagnosed with breast cancer and was treated with TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: disease progression, recurrent cancer, surgery, . TAMOXIFEN dosage: unknown. During the same period patient was treated with ARIMIDEX, PRILOSEC. Patient recovered.
DISEASE PROGRESSION : Durotep Side Effects Report #5661364-4
DUROTEP problem was reported by a Physician from JAPAN on Mar 03, 2008. Male patient, 72 years of age, was diagnosed with cancer pain, insomnia, diarrhoea and was treated with DUROTEP. After drug was administered, patient experienced the following problems/side effects: disease progression, . DUROTEP dosage: unknown. During the same period patient was treated with DECADRON, MYSLEE, LOPEMIN, FESIN, ALDACTONE, LASIX. Patient died on 03/01/2008.
DISEASE PROGRESSION : Dacarbazine Side Effects Report #5661935-5
Physician from UNITED STATES reported DACARBAZINE problem on Mar 10, 2008. Male patient, weighting 179.9 lb, was diagnosed with malignant melanoma and was treated with DACARBAZINE. After drug was administered, patient experienced the following problems/side effects: disease progression, gastrointestinal haemorrhage, mass, . DACARBAZINE dosage: 1600MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Elidel Side Effects Report #5662451-7
ELIDEL problem was reported by a Physician from YUGOSLAVIA on Mar 03, 2008. Female patient, child 8 years of age, was diagnosed with dermatitis atopic and was treated with ELIDEL. After drug was administered, patient experienced the following problems/side effects: disease progression, erythema, pruritus, respiratory tract infection, skin exfoliation, skin tightness, . ELIDEL dosage: unknown. Patient recovered.
DISEASE PROGRESSION : Revlimid Side Effects Report #5662862-X
Physician from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, febrile neutropenia, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/29/2008.
DISEASE PROGRESSION : Velcade Side Effects Report #5663524-5
VELCADE problem was reported by a Physician from JAPAN on Mar 05, 2008. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, platelet count decreased, . VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, NOVAMIN, OXYCONTIN, ETODOLAC. Patient died on 12/14/2007.
DISEASE PROGRESSION : Rebif Side Effects Report #5664186-3
Physician from UNITED STATES reported REBIF problem on Feb 28, 2008. Female patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: disease progression, motor neurone disease, . REBIF dosage: unknown. During the same period patient was treated with NOVANTRONE, CYMBALTA. Patient was hospitalized. Patient died on 04/16/2007.
DISEASE PROGRESSION : Revlimid Side Effects Report #5668559-4
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/16/2008.
DISEASE PROGRESSION : Revlimid Side Effects Report #5668661-7
Physician from UNITED STATES reported REVLIMID problem on Mar 06, 2008. Male patient, 47 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
DISEASE PROGRESSION : Sutent Side Effects Report #5669821-1
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, perirectal abscess, . SUTENT dosage: unknown. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.
DISEASE PROGRESSION : Avastin Side Effects Report #5670016-6
Physician from CANADA reported AVASTIN problem on Mar 06, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, . AVASTIN dosage: unknown. Patient died on 10/01/2007.
DISEASE PROGRESSION : Sutent Side Effects Report #5671328-2
SUTENT problem was reported by a Physician from AUSTRALIA on Mar 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with renal cell carcinoma, constipation, fatigue, wound infection, pain, gastrooesophageal reflux disease, candidiasis and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. During the same period patient was treated with MOVICOL, DEXAMETHASONE, VANCOMYCIN, AMITRIPTYLINE, OXYCONTIN, PANTOPRAZOLE, NILSTAT, COLOXYL WITH SENNA. Patient died.
DISEASE PROGRESSION : Cerezyme Side Effects Report #5671593-1
Physician from JAPAN reported CEREZYME problem on Mar 04, 2008. Male patient, weighting 6.61 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, multi-organ failure, nervous system disorder, . CEREZYME dosage: unknown. During the same period patient was treated with DOPAMINE. Patient died on 03/02/2008.
DISEASE PROGRESSION : Revlimid Side Effects Report #5671680-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.
DISEASE PROGRESSION : Arimidex Side Effects Report #5673108-0
Consumer or non-health professional from BRAZIL reported ARIMIDEX problem on Mar 12, 2008. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with breast cancer, hypertension, hypercholesterolaemia and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: disease progression, . ARIMIDEX dosage: unknown. During the same period patient was treated with ARADOIS H, LIPITOR. Patient recovered.
DISEASE PROGRESSION : Neoral Side Effects Report #5674157-9
NEORAL problem was reported by a Health Professional from UNITED STATES on Mar 10, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence, . NEORAL dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Revlimid Side Effects Report #5675862-0
Physician from UNITED STATES reported REVLIMID problem on Mar 12, 2008. Female patient, 53 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: unknown. Patient died on 03/03/2008.
DISEASE PROGRESSION : Revlimid Side Effects Report #5675870-X
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 52 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, myalgia, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 20 MG, 2 IN 1 D, ORAL. Patient died on 07/01/2007.
DISEASE PROGRESSION : Aldurazyme Side Effects Report #5675952-2
Health Professional from UNITED STATES reported ALDURAZYME problem on Mar 05, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, mucopolysaccharidosis i, . ALDURAZYME dosage: 14.5 MG, 1X/W, INTRAVENOUS. Patient recovered.
DISEASE PROGRESSION : Bevacizumab Side Effects Report #5675958-3
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Male patient, weighting 166.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant neoplasm progression, . BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with ALTACE, PLAVIX, ASPIRIN, LOPRESSOR, HYDROCHLOROTHIAZIDE, VYTORIN, OXALIPLATIN. Patient died on 08/25/2007.
DISEASE PROGRESSION : Sutent Side Effects Report #5676343-0
Consumer or non-health professional from PERU reported SUTENT problem on Mar 11, 2008. Male patient, 46 years of age, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. Patient died on 02/17/2008.
DISEASE PROGRESSION : Ranibizumab Side Effects Report #5676436-8
RANIBIZUMAB problem was reported by a Physician from SWITZERLAND on Mar 10, 2008. Female patient, weighting 141.1 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, hypertension, . RANIBIZUMAB dosage: 0.5 MG, UNK. Patient recovered.
DISEASE PROGRESSION : Climara Side Effects Report #5676837-8
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Feb 21, 2008. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with gastric ulcer and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: disease progression, hot flush, night sweats, . CLIMARA dosage: unknown. During the same period patient was treated with TRANSDERMAL NOS, DIOVAN, NEXIUM. Patient recovered.
DISEASE PROGRESSION : Erlotinib Side Effects Report #5676878-0
ERLOTINIB problem was reported by a Physician from JAPAN on Mar 04, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, hypoxia, . ERLOTINIB dosage: 150 MG QD ORAL. During the same period patient was treated with DECADRON, POLYFUL, EURODIN, FAMOTIDINE, DOMPERIDONE, GASMOTIN, MAGNESIUM OXIDE. Patient recovered.
DISEASE PROGRESSION : Neoral Side Effects Report #5677012-3
Health Professional from UNITED STATES reported NEORAL problem on Mar 14, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence, . NEORAL dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Coviro Side Effects Report #5677264-X
COVIRO problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2008. Male patient, 35 years of age, weighting 99.21 lb, was diagnosed with hiv infection and was treated with COVIRO. After drug was administered, patient experienced the following problems/side effects: disease progression, headache, meningitis cryptococcal, nephropathy toxic, renal failure acute, vomiting, . COVIRO dosage: 300/60 MG DAILY ORAL. During the same period patient was treated with VIRAMUNE, AKURIT, AMPHOTERICIN B. Patient died on 02/22/2008.
DISEASE PROGRESSION : Doxorubicin Side Effects Report #5677271-7
Consumer or non-health professional from FRANCE reported DOXORUBICIN problem on Mar 12, 2008. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic encephalopathy, hepatic failure, hepatitis b virus, . DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, RITUXIMAB, VALACYCLOVIR, BACTRIM. Patient was hospitalized. Patient died.
DISEASE PROGRESSION : Saizen Side Effects Report #5677920-3
SAIZEN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Female patient, child 11 years of age, weighting 66.00 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: disease progression, scoliosis, . SAIZEN dosage: unknown. Patient recovered.
DISEASE PROGRESSION : Tysabri Side Effects Report #5677971-9
Health Professional from UNITED STATES reported TYSABRI problem on Mar 05, 2008. Male patient, 62 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple sclerosis, respiratory failure, . TYSABRI dosage: 300 MG;QM;IV. Patient died on 01/01/2008.
DISEASE PROGRESSION : Velcade Side Effects Report #5678126-4
VELCADE problem was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic function abnormal, hepatic neoplasm, leukaemia, multiple myeloma, petechiae, platelet count decreased, pleural effusion, pneumonia, . VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, ASPIRIN, METHYCOBAL, MAGNESIUM OXIDE, RED BLOOD CELLS, PLATELETS. Patient was hospitalized. Patient died on 10/03/2007.
DISEASE PROGRESSION : Tracleer Side Effects Report #5678203-8
Health Professional from NETHERLANDS reported TRACLEER problem on Mar 06, 2008. Female patient, 69 years of age, was diagnosed with skin ulcer and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: disease progression, extremity necrosis, skin ulcer, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS, IBUPROFEN, ANTIBIOTICS. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Revlimid Side Effects Report #5678216-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 24, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, interstitial lung disease, thrombocytopenia, . REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, CIPRO, AREDIA. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Memantine Side Effects Report #5678405-0
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Mar 06, 2008. Female patient, 72 years of age, was diagnosed with open angle glaucoma and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disease progression, glaucoma, pancreatitis, . MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with AVANDIA, HYDROCODONE, GLIPIZIDE, ALTACE, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, ASPIRIN, DOCUSATE. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Revlimid Side Effects Report #5678689-9
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: 10-5MG, DAILY, ORAL. Patient died.
DISEASE PROGRESSION : Velcade Side Effects Report #5679494-X
Physician from JAPAN reported VELCADE problem on Mar 13, 2008. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, herpes zoster, platelet count decreased, . VELCADE dosage: 1.90 MG/M2,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DECADRON, BICARBONATE, ALENDRONATE, BAKTAR, FAMOTIDINE, OXYCONTIN, ALLOPURINOL. Patient died on 03/01/2008.
DISEASE PROGRESSION : Velcade Side Effects Report #5679620-2
VELCADE problem was reported by a Physician from CROATIA (local name: Hrvatska) on Mar 11, 2008. Female patient, child 1 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, sepsis, thrombocytopenia, . VELCADE dosage: unknown. Patient died.
DISEASE PROGRESSION : Revlimid Side Effects Report #5679672-X
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, . REVLIMID dosage: 25 MG, QD, ORAL. Patient died.
DISEASE PROGRESSION : Myozyme Side Effects Report #5679718-9
MYOZYME problem was reported by a Physician from AUSTRALIA on Mar 07, 2008. Female patient, 63 years of age, weighting 132.3 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, pneumonia aspiration, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
DISEASE PROGRESSION : Lexapro Side Effects Report #5679751-7
Physician from UNITED STATES reported LEXAPRO problem on Mar 14, 2008. Female patient, 60 years of age, was diagnosed with anxiety, depression and was treated with LEXAPRO. After drug was administered, patient experienced the following problems/side effects: disease progression, fall, hereditary spastic paraplegia, . LEXAPRO dosage: 20 MG QD PO. During the same period patient was treated with POSAMAX, TOPRANIL. Patient recovered.